These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 34229852)

  • 21. Extracellular Vesicles as an Efficient and Versatile System for Drug Delivery.
    Dang XTT; Kavishka JM; Zhang DX; Pirisinu M; Le MTN
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-omics analysis identified extracellular vesicles as biomarkers for cardiovascular diseases.
    Meng K; Meng F; Wu Y; Lin L
    Talanta; 2024 Dec; 280():126710. PubMed ID: 39213888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design.
    Kooijmans SAA; de Jong OG; Schiffelers RM
    Adv Drug Deliv Rev; 2021 Jun; 173():252-278. PubMed ID: 33798644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preserving extracellular vesicles for biomedical applications: consideration of storage stability before and after isolation.
    Yuan F; Li YM; Wang Z
    Drug Deliv; 2021 Dec; 28(1):1501-1509. PubMed ID: 34259095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioengineering Extracellular Vesicles for the Treatment of Cardiovascular Diseases.
    Ramasubramanian L; Du S; Gidda S; Bahatyrevich N; Hao D; Kumar P; Wang A
    Adv Biol (Weinh); 2022 Oct; 6(10):e2200087. PubMed ID: 35778828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular vesicles and their nucleic acids for biomarker discovery.
    Momen-Heravi F; Getting SJ; Moschos SA
    Pharmacol Ther; 2018 Dec; 192():170-187. PubMed ID: 30081050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting Inflammatory Vasculature by Extracellular Vesicles.
    Wang S; Dong X; Gao J; Wang Z
    AAPS J; 2018 Feb; 20(2):37. PubMed ID: 29484558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-step magnetic bead-based (2MBB) techniques for immunocapture of extracellular vesicles and quantification of microRNAs for cardiovascular diseases: A pilot study.
    Chen S; Shiesh SC; Lee GB; Chen C
    PLoS One; 2020; 15(2):e0229610. PubMed ID: 32101583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nucleic acid delivery with extracellular vesicles.
    Schulz-Siegmund M; Aigner A
    Adv Drug Deliv Rev; 2021 Jun; 173():89-111. PubMed ID: 33746014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles.
    Davidson SM; Boulanger CM; Aikawa E; Badimon L; Barile L; Binder CJ; Brisson A; Buzas E; Emanueli C; Jansen F; Katsur M; Lacroix R; Lim SK; Mackman N; Mayr M; Menasché P; Nieuwland R; Sahoo S; Takov K; Thum T; Vader P; Wauben MHM; Witwer K; Sluijter JPG
    Cardiovasc Res; 2023 Mar; 119(1):45-63. PubMed ID: 35325061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery.
    Ingato D; Lee JU; Sim SJ; Kwon YJ
    J Control Release; 2016 Nov; 241():174-185. PubMed ID: 27667180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracellular Vesicles: A Brief Overview and Its Role in Precision Medicine.
    Shang M; Ji JS; Song C; Gao BJ; Jin JG; Kuo WP; Kang H
    Methods Mol Biol; 2017; 1660():1-14. PubMed ID: 28828643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis and Biomedical Applications of Functional Cargo in Extracellular Vesicles.
    Qian F; Huang Z; Zhong H; Lei Q; Ai Y; Xie Z; Zhang T; Jiang B; Zhu W; Sheng Y; Hu J; Brinker CJ
    ACS Nano; 2022 Dec; 16(12):19980-20001. PubMed ID: 36475625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Before Translating Extracellular Vesicles into Personalized Diagnostics and Therapeutics: What We Could Do.
    Cheng CA
    Mol Pharm; 2024 Jun; 21(6):2625-2636. PubMed ID: 38771015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Native and bioengineered extracellular vesicles for cardiovascular therapeutics.
    de Abreu RC; Fernandes H; da Costa Martins PA; Sahoo S; Emanueli C; Ferreira L
    Nat Rev Cardiol; 2020 Nov; 17(11):685-697. PubMed ID: 32483304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A brief review on recent advances in diagnostic and therapeutic applications of extracellular vesicles in cardiovascular disease.
    Das D; Jothimani G; Banerjee A; Dey A; Duttaroy AK; Pathak S
    Int J Biochem Cell Biol; 2024 Aug; 173():106616. PubMed ID: 38992790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy.
    De Sousa KP; Rossi I; Abdullahi M; Ramirez MI; Stratton D; Inal JM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jan; 15(1):e1835. PubMed ID: 35898167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation.
    Burnouf T; Agrahari V; Agrahari V
    Int J Nanomedicine; 2019; 14():8847-8859. PubMed ID: 32009783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular Vesicle as a Source of Alzheimer's Biomarkers: Opportunities and Challenges.
    Lee S; Mankhong S; Kang JH
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30965555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.